Reduced T and NK Cell Activity in Glioblastoma Patients Correlates with TIM-3 and BAT3 Dysregulation
Farah Ahmady(Federation University), Rodney B. Luwor(The Royal Melbourne Hospital)
Cited by 6
Related Papers
<p>Ponatinib: a novel multi-tyrosine kinase inhibitor against human malignancies</p>
|OncoTargets and Therapy|2019|197
Targeting Stat3 and Smad7 to restore TGF-β cytostatic regulation of tumor cells in vitro and in vivo
|Oncogene|2012|84